NCT06968273

Brief Summary

This experimental pre-post intervention study aims to evaluate the effect of a respiratory physiotherapy and combined strength and cardiovascular training program on muscle oxygen saturation and functional capacity in patients with Chronic Obstructive Pulmonary Disease (COPD). Oxygenation of the intercostal, quadriceps, and triceps surae muscles will be assessed using near-infrared spectroscopy (NIRS) during standard physical performance tests (6-Minute Walk Test and 30-Second Chair Stand Test). Additional functional parameters and quality of life will be recorded pre- and post-intervention. The results will contribute to optimizing rehabilitation programs and monitoring intensity and progress through muscle oxygenation data.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 2, 2025

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

May 5, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 13, 2025

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

May 13, 2025

Status Verified

May 1, 2025

Enrollment Period

1 month

First QC Date

May 5, 2025

Last Update Submit

May 5, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in muscle oxygen saturation (%)

    Measured in intercostal, quadriceps, and triceps surae muscles using NIRS (Moxy Monitor) during 6MWT and 30CST, before and after the 4-week intervention.

    From baseline to end of intervention (4 weeks)

Secondary Outcomes (7)

  • Distance covered in 6-Minute Walk Test (6MWT)

    From baseline to after the 4-week intervention

  • Number of repetitions in the 30-Second Chair Stand Test

    From baseline to after the 4-week intervention

  • Perceived dyspnea and lower limb fatigue (Borg Scale)

    From baseline to after the 4-week intervention

  • Maximal inspiratory and expiratory pressures (Pimax and Pemax)

    From baseline to after the 4-week intervention

  • FEV1/FEV6 ratio (portable COPD Vitalograph)

    From baseline to after the 4-week intervention

  • +2 more secondary outcomes

Study Arms (1)

Intervention Group

EXPERIMENTAL

Participants will undergo a 4-week combined respiratory physiotherapy and strength-cardio training program, supervised in hospital. Muscle oxygen saturation and functional variables will be measured pre- and post-intervention.

Behavioral: Combined respiratory physiotherapy and cardiovascular-strength training program

Interventions

20-session supervised hospital-based program including respiratory physiotherapy, aerobic training (guided by Borg scale and HR monitoring), and strength training using progressive loads (based on 1RM). Duration: 4 weeks (5 sessions/week).

Intervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years
  • Clinical diagnosis of COPD
  • Medically cleared for physical exercise

You may not qualify if:

  • Decompensated heart failure or exercise-limiting comorbidities
  • Cognitive impairment or legal incapacity to consent
  • Inability to perform physical tasks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unidade Local de Saúde do Alto Alentejo (ULSAALE), Hospitals of Portalegre and Elvas, Portugal

Portalegre, Portugal

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveMotor Activity

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Central Study Contacts

Mª Dolores MD Apolo-Arenas, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

May 5, 2025

First Posted

May 13, 2025

Study Start

May 2, 2025

Primary Completion

June 1, 2025

Study Completion

October 1, 2025

Last Updated

May 13, 2025

Record last verified: 2025-05

Locations